| Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi journal of biological sciences 22 (1), 90-101, 2015 | 736 | 2015 |
| A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians SMD Rizvi, S Shakil, M Haneef EXCLI journal 12, 831, 2013 | 209 | 2013 |
| Mechanistic insights into the antimicrobial actions of metallic nanoparticles and their implications for multidrug resistance S Shaikh, N Nazam, SMD Rizvi, K Ahmad, MH Baig, EJ Lee, I Choi International journal of molecular sciences 20 (10), 2468, 2019 | 173 | 2019 |
| Silver nanoparticles from leaf extract of Mentha piperita: eco-friendly synthesis and effect on acetylcholinesterase activity A Khatoon, F Khan, N Ahmad, S Shaikh, SMD Rizvi, S Shakil, ... Life sciences 209, 430-434, 2018 | 55 | 2018 |
| Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi journal of biological sciences 22 (1), 62-64, 2015 | 52 | 2015 |
| Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals S Shaikh, J Fatima, S Shakil, SMD Rizvi, MA Kamal Saudi Journal of Biological Sciences 22 (1), 37-41, 2015 | 49 | 2015 |
| Current acetylcholinesterase-inhibitors: A neuroinformatics perspective S Shaikh, A Verma, S Siddiqui, S S Ahmad, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 44 | 2014 |
| Forxiga (dapagliflozin): Plausible role in the treatment of diabetes‐associated neurological disorders S Shaikh, SMD Rizvi, S Shakil, S Riyaz, D Biswas, R Jahan Biotechnology and applied biochemistry 63 (1), 145-150, 2016 | 41 | 2016 |
| Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer’s disease-diabetes type 2 linkage via an … S MD Rizvi, S Shakil, D Biswas, S Shakil, S Shaikh, P Bagga, M A Kamal CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 39 | 2014 |
| A novel process for size controlled biosynthesis of gold nanoparticles using bromelain S Khan, SMD Rizvi, M Avaish, M Arshad, P Bagga, MS Khan Materials Letters 159, 373-376, 2015 | 36 | 2015 |
| Synthesis and Characterization of Cefotaxime Conjugated Gold Nanoparticles and Their Use to Target Drug‐Resistant CTX‐M‐Producing Bacterial Pathogens S Shaikh, SMD Rizvi, S Shakil, T Hussain, TM Alshammari, W Ahmad, ... Journal of Cellular Biochemistry 118 (9), 2802-2808, 2017 | 33 | 2017 |
| Multiple targets for the management of Alzheimer’s disease S Sayeed Ahmad, S Akhtar, Q Mohammad Sajid Jamal, M A Kamal, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016 | 32 | 2016 |
| Isolation, partial purification and evaluation of bioactive compounds from leaves of Ageratum houstonianum M Zeeshan, SMD Rizvi, MS Khan, A Kumar Excli Journal 11, 78, 2012 | 31 | 2012 |
| Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease SMD Rizvi, S Shaikh, SMA Waseem, S Shakil, AM Abuzenadah, D Biswas, ... EXCLI journal 14, 684, 2015 | 27 | 2015 |
| In-vitro antibacterial and antioxidant potential of leaf and flower extracts of Vernonia cinerea and their phytochemical constituents SM Danish Rizvi, D Biswas, JM Arif, M Zeeshan Int J Pharm Sci Rev Res 9, 164-169, 2011 | 27 | 2011 |
| Gold nanoparticles: a plausible tool to combat neurological bacterial infections in humans SMD Rizvi, T Hussain, ABF Ahmed, TM Alshammari, A Moin, MQ Ahmed, ... Biomedicine & Pharmacotherapy 107, 7-18, 2018 | 22 | 2018 |
| Pulmonary targeting of inhalable moxifloxacin microspheres for effective management of tuberculosis B Vishwa, A Moin, DV Gowda, S Rizvi, WAH Hegazy, AS Abu Lila, ... Pharmaceutics 13 (1), 79, 2021 | 21 | 2021 |
| Kinetics and molecular docking study of an anti-diabetic drug glimepiride as acetylcholinesterase inhibitor: implication for Alzheimer’s disease-diabetes dual therapy SM Rizvi, S Shaikh, D Naaz, S Shakil, A Ahmad, M Haneef, ... Neurochemical research 41 (6), 1475-1482, 2016 | 21 | 2016 |
| Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: An enzoinformatics approach A Alam, S Shaikh, S S Ahmad, M A Ansari, S Shakil, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 21 | 2014 |
| Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a … S Shaikh, S S Ahmad, M A Ansari, S Shakil, S MD Rizvi, S Shakil, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 19 | 2014 |
